| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/15/2010 | WO2010081173A2 Modified antibody compositions, methods of making and using thereof |
| 07/15/2010 | WO2010080817A2 Carbohydrate-cyclopamine conjugates as anticancer agents |
| 07/15/2010 | WO2010080769A2 Chemotherapeutic methods and compositions |
| 07/15/2010 | WO2010080712A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 07/15/2010 | WO2010080570A2 Tumor therapy with antitumor agents in combination with sindbis virus-based vectors |
| 07/15/2010 | WO2010080506A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/15/2010 | WO2010080474A1 Carbazole and carboline kinase inhibitors |
| 07/15/2010 | WO2010080415A2 Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents |
| 07/15/2010 | WO2010080414A2 Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents |
| 07/15/2010 | WO2010080409A1 Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid |
| 07/15/2010 | WO2010080248A2 Peptides that bind eukaryotic translation initiation factor 4e |
| 07/15/2010 | WO2010080170A1 Combination therapies for neoplastic disorders |
| 07/15/2010 | WO2010080124A2 Nkg2d-fc for immunotherapy |
| 07/15/2010 | WO2010079850A2 Agent for prophylaxis or treatment of cancer |
| 07/15/2010 | WO2010079833A1 Novel cancer antigen eef2 |
| 07/15/2010 | WO2010079668A1 Olefin compound |
| 07/15/2010 | WO2010079423A1 Inhibitors of phosphatidylinositol-3-kinase (pi3) and inducers of nitric oxide (no) |
| 07/15/2010 | WO2010079406A1 Compounds and uses thereof for treating inflammation and modulating immune responses |
| 07/15/2010 | WO2010078945A2 Cancer treatment |
| 07/15/2010 | WO2010078916A1 Immunocytokines for tumour therapy with chemotherapeutic agents |
| 07/15/2010 | WO2010078910A1 Pyridazinone derivatives |
| 07/15/2010 | WO2010078909A1 Pyridazinone derivatives |
| 07/15/2010 | WO2010078905A1 Benzothiazolone derivative |
| 07/15/2010 | WO2010078897A1 Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof |
| 07/15/2010 | WO2010059916A3 Preparation of docetaxel |
| 07/15/2010 | WO2010058032A3 Substituted pyrimidines for the treatment of diseases such as cancer |
| 07/15/2010 | WO2010054107A3 Kinase knockdown via electrophilically enhanced inhibitors |
| 07/15/2010 | WO2010053655A3 Therapeutic methods with withaferin a and analogs |
| 07/15/2010 | WO2010051935A3 Substituted amido phenoxybenzamides |
| 07/15/2010 | WO2010051933A3 Substituted sulphonamido phenoxybenzamides |
| 07/15/2010 | WO2010049816A3 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof |
| 07/15/2010 | WO2010042644A3 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 07/15/2010 | WO2010039762A3 Pharmaceutical compositions comprising boronic acid compounds |
| 07/15/2010 | WO2010037765A3 4 -morpholino-pyrido [3, 2 -d] pyrimidines active on pi3k |
| 07/15/2010 | WO2010036936A9 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents |
| 07/15/2010 | WO2010033871A3 Compositions and methods targeting glutaminase |
| 07/15/2010 | WO2010003520A3 Anti-tumor immunotherapy |
| 07/15/2010 | WO2009150470A3 Suppression of cancers |
| 07/15/2010 | WO2009150469A3 Suppression of neuroendocrine diseases |
| 07/15/2010 | WO2009146034A3 Mapk/erk kinase inhibitors and methods of use thereof |
| 07/15/2010 | WO2009142810A3 Methods for treating or preventing colorectal cancer |
| 07/15/2010 | WO2009135494A3 Alpha-lactalbumin composition for the treatment of actinic keratosis |
| 07/15/2010 | WO2009111278A3 Raf inhibitor compounds and methods of use thereof |
| 07/15/2010 | US20100179304 Somatostatin-Dopamine Chimeric analogs |
| 07/15/2010 | US20100179226 Topical Dosage Form Comprising Tri-Substituted Glycerol Compounds |
| 07/15/2010 | US20100179213 Methods and Compositions Involving miRNAs In Cancer Stem Cells |
| 07/15/2010 | US20100179210 Novel enantiomerically pure compounds for the treatment of proliferative disorders |
| 07/15/2010 | US20100179201 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 07/15/2010 | US20100179200 2-oxothiazolidine 4-carboxylic acid compounds for promoting desquamation of the skin |
| 07/15/2010 | US20100179189 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/15/2010 | US20100179186 USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDS |
| 07/15/2010 | US20100179177 Heterocyclic compounds and their uses |
| 07/15/2010 | US20100179167 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| 07/15/2010 | US20100179163 Nol3 is a predictor of patient outcome |
| 07/15/2010 | US20100179162 Crystal forms of 4-[6-methoxy-7(3-piperidin-1-yl-propoxy) quinazoline-4yl) piperazine-1-carboxylic acid (4-isopropoxyphenyl)-amide |
| 07/15/2010 | US20100179158 Inhibitors of cyclic amp phosphodiesterases |
| 07/15/2010 | US20100179155 Activators and therapeutic applications thereof |
| 07/15/2010 | US20100179149 Aryl ether pyridazinone derivatives |
| 07/15/2010 | US20100179148 Pyridazinone derivatives |
| 07/15/2010 | US20100179147 Benzimidazole compounds and their use as anticancer agents |
| 07/15/2010 | US20100179146 Indolinone Compounds as Kinase Inhibitors |
| 07/15/2010 | US20100179145 Pharmaceutical combinations |
| 07/15/2010 | US20100179144 Quinazoline derivatives as p13 kinase inhibitors |
| 07/15/2010 | US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors |
| 07/15/2010 | US20100179142 Cancer Combination Therapy Comprising AZD2171 and ZD1839 |
| 07/15/2010 | US20100179140 Indenoisoquinolinone analogs and methods of use thereof |
| 07/15/2010 | US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 07/15/2010 | US20100179138 Isozazole Compounds As Inhibitors Of Heat Shock Proteins |
| 07/15/2010 | US20100179136 N-amino tetrahydrothiazine derivatives, method of manufacture and use |
| 07/15/2010 | US20100179134 Pyrimidinediamine kinase inhibitors |
| 07/15/2010 | US20100179132 Carboline derivatives useful in the inhibition of angiogenesis |
| 07/15/2010 | US20100179126 Thiolactams and uses thereof |
| 07/15/2010 | US20100179125 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 07/15/2010 | US20100179124 Thieno-pyridine derivatives as mek inhibitors |
| 07/15/2010 | US20100179120 Novel amide derivative for inhibiting the growth of cancer cells |
| 07/15/2010 | US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold |
| 07/15/2010 | US20100179111 Sigma-1 receptor ligands and methods of use |
| 07/15/2010 | US20100179108 Synthesis of Sodium Narcistatin and Related Compounds |
| 07/15/2010 | US20100179107 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 07/15/2010 | US20100179103 Curcumin cyclodextrin combination for preventing or treating various diseases |
| 07/15/2010 | US20100179098 Furost-5-ene-3, 22, 26-triol glycoside compound for preventing and treatment cancer |
| 07/15/2010 | US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 07/15/2010 | US20100179094 Bispecific egfr/igfir binding molecules |
| 07/15/2010 | US20100178370 Composition for prevention and/or treatment of tumors containing acacia bark derivative |
| 07/15/2010 | US20100178368 Plant extract and its therapeutic use |
| 07/15/2010 | US20100178365 Epicatechin deficient green tea |
| 07/15/2010 | US20100178354 Remedy |
| 07/15/2010 | US20100178344 Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles |
| 07/15/2010 | US20100178337 Composition comprising an active agent with low aqueous solubility |
| 07/15/2010 | US20100178336 Stabilized amorphous forms of imatinib mesylate |
| 07/15/2010 | US20100178328 Combination therapy for ovarian cancer |
| 07/15/2010 | US20100178325 Amphiphilic nucleotide cochleate compositions and methods of using the same |
| 07/15/2010 | US20100178305 Ultrasonic nanotherapy of solid tumors with block copolymers stabilized perfluorocarbon nanodroplets |
| 07/15/2010 | US20100178299 Methods and compositions for improving immune responses |
| 07/15/2010 | US20100178298 Destruction of Tumor Cells by Trifunctional Bispecific Antibodies With Low to Medium Expression Levels of Tumor-Associated Target Antigens |
| 07/15/2010 | US20100178297 Means and methods for the recruitment and identification of stem cells |
| 07/15/2010 | US20100178292 Cryptic glycan markers and applications thereof |
| 07/15/2010 | US20100178291 Pyrrolidinone, Pyrrolidine-2, 5-Dione, Pyrrolidine and Thiosuccinimide Derivatives, Compositions and Methods for Treatment of Cancer |
| 07/15/2010 | US20100178275 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics |